Ensign Peak Advisors, Inc Emergent Bio Solutions Inc. Transaction History

Ensign Peak Advisors, Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$20.09 - $35.8 $22,299 - $39,738	-1,110 Reduced 6.21%	16,766 $352,000
Q4 2021 Feb 11, 2022	SELL	$33.11 - $55.01 $660,875 - $1.1 Million	-19,960 Reduced 52.75%	17,876 $777,000
Q2 2021 Aug 13, 2021	SELL	$56.61 - $80.46 $673,432 - $957,152	-11,896 Reduced 23.92%	37,836 $2.38 Million
Q1 2021 May 12, 2021	SELL	$86.23 - $125.19 $522,295 - $758,275	-6,057 Reduced 10.86%	49,732 $4.62 Million
Q4 2020 Feb 12, 2021	BUY	$79.17 - $111.47 $160,794 - $226,395	2,031 Added 3.78%	55,789 $5 Million
Q3 2020 Nov 12, 2020	BUY	$81.91 - $134.94 $1.3 Million - $2.15 Million	15,922 Added 42.08%	53,758 $5.56 Million
Q1 2020 May 11, 2020	BUY	$49.34 - $68.76 $138,152 - $192,528	2,800 Added 7.99%	37,836 $2.19 Million
Q4 2019 Feb 14, 2020	BUY	$51.21 - $59.06 $1.79 Million - $2.07 Million	35,036 New	35,036 $1.89 Million

159

33.7M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $473M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.